Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.3 USD | -6.67% | -9.48% | +124.20% |
May. 09 | Black Diamond Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 11 | Black Diamond Therapeutics, Inc. Announces Board and Committee Changes | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 355M |
---|---|---|---|---|---|
Net income 2024 * | -93M | Net income 2025 * | -121M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.66
x | P/E ratio 2025 * |
-3.88
x | Employees | 54 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.51% |
1 day | -2.74% | ||
1 week | +2.43% | ||
Current month | +21.18% | ||
1 month | +25.93% | ||
3 months | +59.57% | ||
6 months | +275.00% | ||
Current year | +140.21% |
Managers | Title | Age | Since |
---|---|---|---|
Elizabeth Buck
FOU | Founder | 49 | 13-12-31 |
Mark Velleca
CEO | Chief Executive Officer | 60 | 21-08-08 |
David Epstein
FOU | Founder | 65 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Epstein
FOU | Founder | 65 | 13-12-31 |
Mark Velleca
CEO | Chief Executive Officer | 60 | 21-08-08 |
Ali Behbahani
BRD | Director/Board Member | 47 | 18-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 6.31 | -6.52% | 428 916 |
24-05-09 | 6.75 | -2.74% | 652,124 |
24-05-08 | 6.94 | -3.61% | 459,647 |
24-05-07 | 7.2 | -2.57% | 1,014,682 |
24-05-06 | 7.39 | +6.18% | 896,781 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+140.21% | 355M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.85% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- BDTX Stock